119 related articles for article (PubMed ID: 4713781)
1. Standardization of microcytotoxicity assay for cell-mediated immunity.
O'Toole C
Natl Cancer Inst Monogr; 1973 Jun; 37():19-24. PubMed ID: 4713781
[No Abstract] [Full Text] [Related]
2. Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop.
Bean MA; Bloom BR; Herberman RB; Old LJ; Oettgen HF; Klein G; Terry WD
Cancer Res; 1975 Oct; 35(10):2902-13. PubMed ID: 1157057
[No Abstract] [Full Text] [Related]
3. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
Perlmann P; O'Toole C; Unsgaard B
Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
[No Abstract] [Full Text] [Related]
4. Murine bladder tumors as models for human tumor immunity.
Hellström I; Hellström KE
Natl Cancer Inst Monogr; 1972 Dec; 35():125-7. PubMed ID: 4659043
[No Abstract] [Full Text] [Related]
5. Cell-mediated immune mechanisms of tumor cell destruction.
Perlmann P; O'Toole C; Unsgaard B
Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
[No Abstract] [Full Text] [Related]
6. The cellular immune response to carcinoma of the urinary bladder: correlation to clinical stage and treatment.
O'Toole C; Unsgaard B; Almgård LE; Johansson B
Br J Cancer Suppl; 1973 Aug; 1():266-75. PubMed ID: 4804285
[TBL] [Abstract][Full Text] [Related]
7. The specificity of the microcytotoxicity assay for cell-mediated immunity in human bladder cancer.
Vilien M; Wolf H
J Urol; 1978 Mar; 119(3):338-42. PubMed ID: 273706
[TBL] [Abstract][Full Text] [Related]
8. Studies on specificity of cell-mediated immunity to human tumors.
Takasugi M; Mickey MR; Terasaki PI
J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
[No Abstract] [Full Text] [Related]
9. Assessment of cell-mediated immunity to human tumor-associated antigens.
Baldwin RW; Embeton MJ
Int Rev Exp Pathol; 1977; 17():49-95. PubMed ID: 849883
[No Abstract] [Full Text] [Related]
10. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
Takasugi M; Kinoshita K
J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
[No Abstract] [Full Text] [Related]
11. Disease and non-disease-related cell-mediated cytotoxicity in humans.
Bloom ET; Seeger RC
Cancer Res; 1976 Apr; 36(4):1361-6. PubMed ID: 1260761
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated cytotoxicity against human bladder cancer.
Bloom ET; Ossorio RC; Brosman SA
Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
[No Abstract] [Full Text] [Related]
13. Lymphocyte mediated cytotoxicity to tumor antigens.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
[No Abstract] [Full Text] [Related]
14. In vitro cytotoxicity studies in bladder and renal cell cancer.
Elhilali MM; Nayak SK
Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
[TBL] [Abstract][Full Text] [Related]
15. Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.
O'Toole C; Perlmann P; Unsgaard B; Moberger G; Edsmyr F
Int J Cancer; 1972 Jul; 10(1):77-91. PubMed ID: 4196436
[No Abstract] [Full Text] [Related]
16. Effect of therapy and tumour stage on cellular immunity to bladder carcinoma.
O'Toole CM
Adv Exp Med Biol; 1973; 29(0):477-82. PubMed ID: 4794920
[No Abstract] [Full Text] [Related]
17. Evaluation of a cell-mediated cytotoxicity assay utilizing 125 iododeoxyuridine-labeled tissue-culture target cells.
Oldham RK; Siwarski D; McCoy JL; Plata EJ; Herberman RB
Natl Cancer Inst Monogr; 1973 Jun; 37():49-58. PubMed ID: 4268324
[No Abstract] [Full Text] [Related]
18. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
Hakala TR
Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
[TBL] [Abstract][Full Text] [Related]
19. Cellular microcytotoxicity in human tumor systems: analysis of results.
Oldham RK; Djeu JY; Cannon GB; Siwarski D; Herberman RB
J Natl Cancer Inst; 1975 Dec; 55(6):1305-18. PubMed ID: 54436
[TBL] [Abstract][Full Text] [Related]
20. Prelabeling target cells with 3 H-proline as a method for studying lymphocyte cytotoxicity.
Bean MA; Pees H; Rosen G; Oettgen HF
Natl Cancer Inst Monogr; 1973 Jun; 37():41-8. PubMed ID: 4713785
[No Abstract] [Full Text] [Related]
[Next] [New Search]
